More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.
Moodie
Peter
P
D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000191:economics / Q000627:therapeutic use; D009313:National Health Programs / Q000191:economics; D009520:New Zealand
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine